CN101795676B - 包含酵母的药物产品 - Google Patents

包含酵母的药物产品 Download PDF

Info

Publication number
CN101795676B
CN101795676B CN2008801050759A CN200880105075A CN101795676B CN 101795676 B CN101795676 B CN 101795676B CN 2008801050759 A CN2008801050759 A CN 2008801050759A CN 200880105075 A CN200880105075 A CN 200880105075A CN 101795676 B CN101795676 B CN 101795676B
Authority
CN
China
Prior art keywords
yeast
drug products
coating
saccharomyces
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008801050759A
Other languages
English (en)
Chinese (zh)
Other versions
CN101795676A (zh
Inventor
博多·阿斯穆森
克里斯蒂安妮·席勒
维尔纳·韦茨切斯
格雷戈尔·高尔鲍茨
马哈茂德·A·奥默-亚当
斯特凡·纳格尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40299087&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN101795676(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of CN101795676A publication Critical patent/CN101795676A/zh
Application granted granted Critical
Publication of CN101795676B publication Critical patent/CN101795676B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/064Saccharomycetales, e.g. baker's yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN2008801050759A 2007-09-01 2008-08-21 包含酵母的药物产品 Expired - Fee Related CN101795676B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102007041588.7 2007-09-01
DE102007041588A DE102007041588A1 (de) 2007-09-01 2007-09-01 Arzneimittel mit Hefe
PCT/EP2008/006897 WO2009052888A2 (de) 2007-09-01 2008-08-21 Arzneimittel mit hefe

Publications (2)

Publication Number Publication Date
CN101795676A CN101795676A (zh) 2010-08-04
CN101795676B true CN101795676B (zh) 2012-11-28

Family

ID=40299087

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008801050759A Expired - Fee Related CN101795676B (zh) 2007-09-01 2008-08-21 包含酵母的药物产品

Country Status (14)

Country Link
US (1) US20120027856A1 (enExample)
EP (1) EP2180885B1 (enExample)
JP (1) JP2010536903A (enExample)
KR (1) KR101259673B1 (enExample)
CN (1) CN101795676B (enExample)
AU (1) AU2008316051A1 (enExample)
CA (1) CA2698327C (enExample)
DE (1) DE102007041588A1 (enExample)
ES (1) ES2456267T3 (enExample)
MX (1) MX2010002167A (enExample)
NZ (1) NZ584233A (enExample)
RU (1) RU2452473C2 (enExample)
WO (1) WO2009052888A2 (enExample)
ZA (1) ZA201000853B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009027938A1 (de) * 2009-07-22 2011-01-27 Universität Greifswald Orales therapeutisches System und seine Verwendung
US10282291B2 (en) * 2012-04-20 2019-05-07 Enmotus, Inc. Storage system with data management mechanism and method of operation thereof
WO2015190456A1 (ja) * 2014-06-10 2015-12-17 ライオン株式会社 清酒酵母を含有する錠剤
US11291683B2 (en) * 2016-04-01 2022-04-05 Access Business Group International Llc Bilayer tablets of B vitamins and process for preparing the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675174A (en) * 1985-08-16 1987-06-23 Alza Corporation Veterinary dispenser delivering beneficial agent by gas power generated in situ
AU646232B2 (en) 1989-10-02 1994-02-17 Cima Labs, Inc. Effervescent dosage form and method of administering same
DK1183014T3 (da) * 1999-06-14 2004-02-09 Cosmo Spa Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
DE10120092B4 (de) * 2001-04-25 2008-03-20 Lts Lohmann Therapie-Systeme Ag Magensaftresistente Vorrichtung zur Freisetzung von mukoadhäsiven Wirkstoffträgern und Verfahren zur Herstellung der magensaftresistenten Vorrichtung
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
WO2002102415A1 (en) * 2001-06-18 2002-12-27 Blue Cross Laboratories Limited Gastric floating system
WO2003000112A2 (en) 2001-06-20 2003-01-03 The Governement Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of ribonuclease l in diagnosis of cancer
DE10224607B4 (de) * 2002-06-04 2008-03-13 Lts Lohmann Therapie-Systeme Ag Filmförmige, zerfallsfähige Zubereitungen zur Wirkstofffreisetzung und Verfahren zu deren Herstellung
CA2501345A1 (en) * 2002-10-11 2004-04-22 Depomed Development, Ltd. Gastro-retentive levodopa delivery form
US6835397B2 (en) * 2002-12-23 2004-12-28 Balchem Corporation Controlled release encapsulated bioactive substances
US20060003003A1 (en) 2004-06-28 2006-01-05 Bakker Johan A Oral sustained release formulation of tedisamil with gastric retention properties
DE102004042139B4 (de) 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US7799328B2 (en) * 2004-12-23 2010-09-21 Biocodex Method for treating weight loss in patients suffering from inflammatory bowel diseases
AU2008273095A1 (en) * 2007-07-12 2009-01-15 Dsm Ip Assets B.V. Nitrate reduction by a probiotic in the presence of a heme

Also Published As

Publication number Publication date
ES2456267T3 (es) 2014-04-21
NZ584233A (en) 2012-02-24
EP2180885B1 (de) 2014-01-29
AU2008316051A1 (en) 2009-04-30
RU2452473C2 (ru) 2012-06-10
RU2010109523A (ru) 2011-10-20
US20120027856A1 (en) 2012-02-02
JP2010536903A (ja) 2010-12-02
KR101259673B1 (ko) 2013-05-06
CA2698327C (en) 2013-04-30
CN101795676A (zh) 2010-08-04
WO2009052888A2 (de) 2009-04-30
DE102007041588A1 (de) 2009-03-05
CA2698327A1 (en) 2009-04-30
MX2010002167A (es) 2010-04-29
KR20100059880A (ko) 2010-06-04
ZA201000853B (en) 2010-10-27
WO2009052888A3 (de) 2009-10-15
EP2180885A2 (de) 2010-05-05

Similar Documents

Publication Publication Date Title
EP1993517B1 (en) Modified release formulations and methods of treating inflammatory bowel disease
TWI233809B (en) Dosage forms for providing effective reboxetine therapy with once-a-day dosing
CN103142552A (zh) 一种洛伐他汀肠溶缓释微丸胶囊及其制备方法
CN101795676B (zh) 包含酵母的药物产品
KR20060076331A (ko) 테르비나핀을 포함하는 제약학적 조성물 및 그의 용도
CN101301281A (zh) 一种渗透泵控释胶囊壳及其制备方法
CN101428005A (zh) 泮托拉唑及其钠盐肠溶缓释微丸制剂
CN101732276A (zh) 一种单硝酸异山梨酯的片剂
CN102178677B (zh) 硝苯地平双层渗透泵药物组合物及其制备工艺
CN102920707A (zh) 一种复方抗结核制剂的制备工艺
CN106511293A (zh) 含有达方吡啶的缓释口服制剂及其用途
CN105055360A (zh) 一种盐酸哌唑嗪控释片及其制备方法
CN100427084C (zh) 口服水飞蓟素缓释制剂及其制备方法
CN104288107A (zh) 漂浮缓释微丸、含有该微丸的药物组合物及其制备方法
CN101642443A (zh) 单硝酸异山梨酯渗透泵型控释制剂及其制备方法
EP4299056A1 (en) Sleep regulation tablet allowing release by stage and preparation method therefor
CN103142618A (zh) 一种琥珀酸美托洛尔氢氯噻嗪缓释微丸胶囊及其制备方法
CN104224728A (zh) 一种埃索美拉唑肠溶微丸及其制备方法
CN102238944A (zh) 用于制备生物粘附压制基质的方法
CN102920662B (zh) 一种泛昔洛韦缓释微丸、其制备方法及应用
CN101099762B (zh) 珍菊降压缓释制剂
US20100143472A1 (en) Osmotic form for controlled release of active principles
US20060280788A1 (en) Delivery and formulations of mast cell stabilizers
CN101869711A (zh) 含有利尿剂类降血压药物和双胍类降糖药物的药物组合物及其用途
WO2013051036A1 (en) Use of pharmaceutical composition for gastroretentive sustained and pulsatile drug delivery system

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20121128

Termination date: 20140821

EXPY Termination of patent right or utility model